The Future of Biomedical HIV Prevention Trials: Researcher Viewpoints and Community Survey
This report aims to make more accessible to community advocates discussions around ethical conduct of biomedical prevention trials in the era of PrEP. In early 2019, TAG, along with Black AIDS Institute and the HIV Vaccine Trials Network developed an…
Protestors Demand Cepheid Halve the Price of GeneXpert TB Tests to US$5
Public Investments in TB Medicine Bedaquiline Far Exceed Those of Developer Johnson & Johnson
ACT NOW: END AIDS Coalition to Offer Community Leadership Grants
October 21, 2019 – The ACT NOW: END AIDS (ANEA) coalition is seeking proposals for a new small grants program that aims to significantly increase local and state community leadership as part of the new federal Ending the HIV Epidemic…
Forging A Path to HCV Elimination: Simpler Tests and Affordable Generics
In July 2017, 37 treatment activists from 17 countries—including 14 low- and middle-income countries (LMICs)—met with representatives from three generics and three diagnostics companies. This Hepatitis C World Community Advisory Board meeting was an opportunity for activists to present demands…